149 related articles for article (PubMed ID: 4015713)
1. In vitro inhibition of animal and higher plants 2,3-oxidosqualene-sterol cyclases by 2-aza-2,3-dihydrosqualene and derivatives, and by other ammonium-containing molecules.
Duriatti A; Bouvier-Nave P; Benveniste P; Schuber F; Delprino L; Balliano G; Cattel L
Biochem Pharmacol; 1985 Aug; 34(15):2765-77. PubMed ID: 4015713
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of 2,3-oxidosqualene cyclases.
Taton M; Benveniste P; Rahier A; Johnson WS; Liu HT; Sudhakar AR
Biochemistry; 1992 Sep; 31(34):7892-8. PubMed ID: 1510977
[TBL] [Abstract][Full Text] [Related]
3. N-[(1,5,9)-trimethyl-decyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol a novel potent inhibitor of 2,3-oxidosqualene cycloartenol and lanosterol cyclases.
Taton M; Benveniste P; Rahier A
Biochem Biophys Res Commun; 1986 Jul; 138(2):764-70. PubMed ID: 3741433
[TBL] [Abstract][Full Text] [Related]
4. 2,3-Epoxy-10-aza-10,11-dihydrosqualene, a high-energy intermediate analogue inhibitor of 2,3-oxidosqualene cyclase.
Ceruti M; Balliano G; Viola F; Grosa G; Rocco F; Cattel L
J Med Chem; 1992 Aug; 35(16):3050-8. PubMed ID: 1501233
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of 2,3-oxidosqualene cyclase and sterol biosynthesis by 10- and 19-azasqualene derivatives.
Viola F; Brusa P; Balliano G; Ceruti M; Boutaud O; Schuber F; Cattel L
Biochem Pharmacol; 1995 Sep; 50(6):787-96. PubMed ID: 7575639
[TBL] [Abstract][Full Text] [Related]
6. 22,23-Epoxy-2-aza-2,3-dihydrosqualene derivatives: potent new inhibitors of squalene 2,3-oxide-lanosterol cyclase.
Viola F; Ceruti M; Balliano G; Caputo O; Cattel L
Farmaco; 1990 Sep; 45(9):965-78. PubMed ID: 2282128
[TBL] [Abstract][Full Text] [Related]
7. The squalene-2,3-epoxide cyclase as a model for the development of new drugs.
Cattel L; Ceruti M; Viola F; Delprino L; Balliano G; Duriatti A; Bouvier-Navé P
Lipids; 1986 Jan; 21(1):31-8. PubMed ID: 3515096
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory activity of 8-azadecalin derivatives towards 2,3-oxidosqualene:lanosterol cyclases from baker's yeast and pig's liver.
Hoshino T; Kobayashi N; Ishibashi E; Hashimoto S
Biosci Biotechnol Biochem; 1995 Apr; 59(4):602-9. PubMed ID: 7772824
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 2,3-oxidosqualene: beta-amyrin-cyclase, S-adenosyl-L-methionine: cycloartenol C-24-methyltransferase and cycloeucalenol: obtusifoliol isomerase by rationally designed molecules containing a tertiary amine function.
Rahier A; Bouvier P; Cattel L; Narula A; Benveniste P
Biochem Soc Trans; 1983 Oct; 11(5):537-43. PubMed ID: 6642064
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cholesterol biosynthesis in 3T3 fibroblasts by 2-aza-2,3-dihydrosqualene, a rationally designed 2,3-oxidosqualene cyclase inhibitor.
Gerst N; Schuber F; Viola F; Cattel L
Biochem Pharmacol; 1986 Dec; 35(23):4243-50. PubMed ID: 3790151
[TBL] [Abstract][Full Text] [Related]
11. 2,3-Oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors.
Cattel L; Ceruti M; Balliano G; Viola F; Grosa G; Rocco F; Brusa P
Lipids; 1995 Mar; 30(3):235-46. PubMed ID: 7791532
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and inhibition studies of sulfur-substituted squalene oxide analogues as mechanism-based inhibitors of 2,3-oxidosqualene-lanosterol cyclase.
Stach D; Zheng YF; Perez AL; Oehlschlager AC; Abe I; Prestwich GD; Hartman PG
J Med Chem; 1997 Jan; 40(2):201-9. PubMed ID: 9003518
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of fungal and mammalian sterol biosynthesis by 2-aza-2,3-dihydrosqualene.
Ryder NS; Dupont MC; Frank I
FEBS Lett; 1986 Aug; 204(2):239-42. PubMed ID: 3525224
[TBL] [Abstract][Full Text] [Related]
14. Rationally designed inhibitors as tools for comparing the mechanism of squalene-hopene cyclase with oxidosqualene cyclase.
Viola F; Ceruti M; Cattel L; Milla P; Poralla K; Balliano G
Lipids; 2000 Mar; 35(3):297-303. PubMed ID: 10783007
[TBL] [Abstract][Full Text] [Related]
15. Drug design based on biosynthetic studies: synthesis, biological activity, and kinetics of new inhibitors of 2,3-oxidosqualene cyclase and squalene epoxidase.
Cattel L; Ceruti M; Balliano G; Viola F; Grosa G; Schuber F
Steroids; 1989; 53(3-5):363-91. PubMed ID: 2678608
[TBL] [Abstract][Full Text] [Related]
16. Potent inhibition of cholesterol biosynthesis in 3T3 fibroblasts by N-[(1,5,9)-trimethyldecyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol, a new 2,3-oxidosqualene cyclase inhibitor.
Gerst N; Duriatti A; Schuber F; Taton M; Benveniste P; Rahier A
Biochem Pharmacol; 1988 May; 37(10):1955-64. PubMed ID: 3377803
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cholesterol biosynthesis in Chinese hamster ovary cells by 4,4,10 beta-trimethyl-trans-decal-3 beta-ol. A specific 2,3-oxidosqualene cyclase inhibitor.
Chang TY; Schiavoni ES; McCrae KR; Nelson JA; Spencer TA
J Biol Chem; 1979 Nov; 254(22):11258-63. PubMed ID: 500643
[No Abstract] [Full Text] [Related]
18. In vitro susceptibility of fungi to acyclic inhibitors of 2,3-oxidosqualene cyclases.
Airaudi D; Ceruti M; Bianco C; Filipello Marchisio V
Mycoses; 1996; 39(1-2):51-6. PubMed ID: 8786759
[TBL] [Abstract][Full Text] [Related]
19. Effects of a 2,3-oxidosqualene-lanosterol cyclase inhibitor 2,3:22,23-dioxidosqualene and 24,25-epoxycholesterol on the regulation of cholesterol biosynthesis in human hepatoma cell line HepG2.
Dollis D; Schuber F
Biochem Pharmacol; 1994 Jul; 48(1):49-57. PubMed ID: 8043030
[TBL] [Abstract][Full Text] [Related]
20. Affinity labeling of vertebrate oxidosqualene cyclases with a tritiated suicide substrate.
Abe I; Bai M; Xiao XY; Prestwich GD
Biochem Biophys Res Commun; 1992 Aug; 187(1):32-8. PubMed ID: 1520315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
